New cholesterol drug put to the test in healthy adults
NCT ID NCT07152873
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This early-stage study tests a new drug for mixed dyslipidemia (high cholesterol and fats in the blood) in 60 healthy adults. Participants will receive two different versions of the drug to compare how the body absorbs and processes them. The goal is to gather safety and drug-level information, not to treat the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.